Madiha DEROUAZI
7Patents
3h-index
3Co-inventors
46Inventor score
Filing activity: Mar 9, 2012 → Apr 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9657064B2 | Cell penetrating peptides | Chemistry; Metallurgy | 6 | Active |
| US9187534B2 | Multi-epitopic vaccine | Emerging Cross-Sectional Technologies | 5 | Active |
| US11338027B2 | Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer | Human Necessities | 4 | Active |
| US12214048B2 | Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine | Chemistry; Metallurgy | 0 | Active |
| US12178788B2 | Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist | Emerging Cross-Sectional Technologies | 0 | Active |
| US12220387B2 | Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer | Human Necessities | 0 | Active |
| US12220450B2 | Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.